Abstract
An increase in apoptotic cells may be observed after treatment with chemotherapy, and many authors have assumed that anti-cancer drugs kill cells by inducing apoptosis. The most relevant endpoint of cell death following treatment of tumour cells is loss of reproductive ability as measured by a colony-forming assay, since cells with limited reproductive potential cannot regenerate a tumour. We have therefore investigated the relationship between apoptosis and reproductive cell death following in vitro treatment of mammalian cell lines with anti-cancer drugs. Markers of apoptosis (DNA ladders, TUNEL assay) were evaluated at various times after treatment of Chinese Hamster Ovary (CHO) cells, human bladder cancer MGH-U1 cells, and a murine T-lymphocytic cell line (CTLL-2) with several anti-cancer drugs. These markers were found infrequently, despite the use of doses that cause loss of colony-forming ability, except in CTLL-2 cells. We also transfected and expressed the human pro-apoptotic gene bax and the anti-apoptotic gene bcl-2 in MGH-U1 cells and compared cell survival after drug treatment with that of control cells transfected with the vector alone. Expression of these genes had at most small effects to influence cell survival. We conclude that apoptotic mechanisms had at most a minor role in leading to reproductive death of MGH-U1 and CHO cells after chemotherapy. When apoptosis is observed following treatment with anti-cancer drugs it may be a secondary event which occurs in lethally-damaged cells, leading to their lysis, rather than a primary event that leads to loss of reproductive integrity. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aldridge DR, Arends MJ and Radford IR (1995) Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. Br J Cancer 71: 571–577
Beale P, Rogers P, Hobbs S, Boxall F and Kelland L (1998) Transfection of bax into resistant human ovarian carcinoma cell lines confers no sensitisation to chemotherapeutic agents. Br J Cancer 78: 30
Brezden CB, McClelland RA and Rauth AM (1994) Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole. Biochem Pharmacol 48: 361–370
Brown JM and Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59: 1391–1399
Chang FL and Lai MD (2000) The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines. Anticancer Res 20: 351–355
Hu T, Miller CM, Ridder GM and Aardema MJ (1999) Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res 426: 51–62
Hu ZB, Yang GS, Li M, Miyamoto N, Minden MD and McCulloch EA (1995) Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Leukemia 9: 789–798
Kramer MH, Hermans J, Parker J, Krol AD, Kluin-Nelemans JC, Haak HL, van Groningen K, van Krieken JH, de Jong D and Kluin PM (1996) Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol 14: 2131–2138
Kyprianou N, King ED, Bradbury D and Rhee JG (1997) bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 70: 341–348
Lock RB and Strabinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56: 4006–4012
Pereira H, Silva S, Juliao R, Gracia P and Perpetua F (1997) Prognostic markers for colorectal cancer: expression of p53 and BCL2. World J Surg 21: 210–213
Roper PR and Drewinko B (1976) Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res 36: 2182–2188
Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K and Takahashi T (1996) Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 67: 101–105
Smets LA (1994) Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-cancer Drugs 5: 3–9
Tai YT, Lee S, Niloff E, Weisman C, Strobel T and Cannistra SA (1998) BAX protein expression and clinical outcome in epithelial ovarian cancer. J Clin Oncol 16: 2583–2590
Veronese S, Mauri FA, Caffo O, Scaioli M, Aldovini D, Perrone G, Galligioni E, Doglioni C, Dalla Palma P and Barbareschi M (1998) Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. Int J Cancer 79: 13–18
Yin DX and Schimke RT (1995) BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 55: 4922–4928
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tannock, I., Lee, C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br J Cancer 84, 100–105 (2001). https://doi.org/10.1054/bjoc.2000.1538
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1538
Keywords
This article is cited by
-
Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status
Journal of Biosciences (2017)
-
Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes
Tumor Biology (2015)
-
Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines
Journal of Biosciences (2012)
-
The role of apoptotic cell death in the radiosensitising effect of gemcitabine
British Journal of Cancer (2009)
-
Could 99mTc-glucarate be used to evaluate tumour necrosis?
European Journal of Nuclear Medicine and Molecular Imaging (2008)